GC
AMPE

Guggenheim Capital’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Guggenheim Capital’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-72
Closed -$73K – 2676
2018
Q1 		$73K Buy
72
+6
+9% +$5.02K ﹤0.01% 2679
2017
Q4 		$80K Sell
66
-11
-14% -$5.17K ﹤0.01% 2616
2017
Q3 		$14K Hold
77
– – ﹤0.01% 2770
2017
Q2 		$12K Sell
77
-5
-6% -$1.01K ﹤0.01% 2803
2017
Q1 		$19K Hold
82
– – ﹤0.01% 2789
2016
Q4 		$23K Buy
82
+1
+1% +$238 ﹤0.01% 2841
2016
Q3 		$18K Buy
81
+27
+50% +$7.57K ﹤0.01% 2836
2016
Q2 		$21K Buy
54
+5
+10% +$5.46K ﹤0.01% 2809
2016
Q1 		$33K Buy
+49
New +$33K ﹤0.01% 2807
2015
Q2 		– Sell
-49
Closed -$110K – 3113
2015
Q1 		$110K Buy
49
+2
+4% +$3.41K ﹤0.01% 2854
2014
Q4 		$49K Buy
+47
New +$50.2K ﹤0.01% 2916
2014
Q3 		– Sell
-78
Closed -$197K – 3160
2014
Q2 		$197K Sell
78
-4
-5% -$8.16K ﹤0.01% 2907
2014
Q1 		$156K Buy
82
+21
+34% +$49.7K ﹤0.01% 2946
2013
Q4 		$131K Buy
61
+4
+7% +$9.46K ﹤0.01% 2932
2013
Q3 		$129K Buy
57
+1
+2% +$1.93K ﹤0.01% 2817
2013
Q2 		$98K Buy
+56
New +$88.9K ﹤0.01% 2826

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Guggenheim Capital's AMPE Position: Q2 2018 in Review

Guggenheim Capital sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 72 shares — an estimated $73K sold.

Guggenheim Capital first reported a position in AMPE in Q2 2013 and held it in 16 quarters. The position peaked at $197K in Q2 2014. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Guggenheim Capital reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 72 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $73K.
  • Guggenheim Capital first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 16 quarters.
  • Guggenheim Capital's Ampio Pharmaceuticals Inc. position peaked at $197K in Q2 2014.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.